Antiretroviral treatment start-time during primary SIV(mac) infection in macaques exerts a different impact on early viral replication and dissemination
about
Animal Models for HIV Cure ResearchConsiderations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategiesUsing nonhuman primates to model HIV transmissionEfficacy of HIV Postexposure Prophylaxis: Systematic Review and Meta-analysis of Nonhuman Primate StudiesAnti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infectionImpact of short-term HAART initiated during the chronic stage or shortly post-exposure on SIV infection of male genital organs.Simian Immunodeficiency Virus SIVsab Infection of Rhesus Macaques as a Model of Complete Immunological Suppression with Persistent Reservoirs of Replication-Competent Virus: Implications for Cure Research.Characterization of peripheral and mucosal immune responses in rhesus macaques on long-term tenofovir and emtricitabine combination antiretroviral therapy.Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system.Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy.Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.Role of Monocyte/Macrophages during HIV/SIV Infection in Adult and Pediatric Acquired Immune Deficiency Syndrome.Epigenetic Modulation of CD8⁺ T Cell Function in Lentivirus Infections: A Review.
P2860
Q26767476-040C2073-B12F-4D75-B52C-F621C0C10DF4Q26825814-B0EB8F9F-E9AF-4F3C-9B22-93E5BB1190B5Q26861425-FF3F4AA6-3949-4010-89F8-7DE25FB14D8AQ27021082-4B6FDD94-526D-4209-8CB9-844A5468A6ACQ27322602-998276C3-A874-484E-BF9A-9A97945FD934Q34278020-9191474D-2A5C-43A8-9730-F62F2D181977Q35641175-AE444B14-4231-498A-BB66-E32279A96B24Q36389032-31543C82-AE62-49DD-9E5B-B9BF169471C9Q37406571-92621363-B261-4D5C-BC16-8AC8A79C1E45Q37829628-E246E7E5-C7FB-4DCD-9DB8-134910E9105CQ39315703-661E5A4F-B7BC-41F4-83F4-A0480A272047Q45326424-EC1419CC-DC47-4EC7-A765-37F1D6E08B33Q47100536-47644014-758D-4923-81C5-40F9F36CF75CQ54942553-03563A8B-31EB-4CD0-A32D-73C457C0F062
P2860
Antiretroviral treatment start-time during primary SIV(mac) infection in macaques exerts a different impact on early viral replication and dissemination
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Antiretroviral treatment start-time during primary SIV
@nl
Antiretroviral treatment start ...... replication and dissemination
@ast
Antiretroviral treatment start ...... replication and dissemination
@en
type
label
Antiretroviral treatment start-time during primary SIV
@nl
Antiretroviral treatment start ...... replication and dissemination
@ast
Antiretroviral treatment start ...... replication and dissemination
@en
prefLabel
Antiretroviral treatment start-time during primary SIV
@nl
Antiretroviral treatment start ...... replication and dissemination
@ast
Antiretroviral treatment start ...... replication and dissemination
@en
P2093
P2860
P1433
P1476
Antiretroviral treatment start ...... replication and dissemination
@en
P2093
Abdelkrim Mannioui
Benoit Delache
Julien Calvo
Olivier Bourry
Patricia Brochard
Pierre Sellier
Sophie Prévot
P2860
P304
P356
10.1371/JOURNAL.PONE.0010570
P407
P577
2010-05-11T00:00:00Z